143 related articles for article (PubMed ID: 20491776)
1. P300/CBP-associated factor regulates Y-box binding protein-1 expression and promotes cancer cell growth, cancer invasion and drug resistance.
Shiota M; Yokomizo A; Tada Y; Uchiumi T; Inokuchi J; Tatsugami K; Kuroiwa K; Yamamoto K; Seki N; Naito S
Cancer Sci; 2010 Aug; 101(8):1797-806. PubMed ID: 20491776
[TBL] [Abstract][Full Text] [Related]
2. Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells.
Shiota M; Yokomizo A; Itsumi M; Uchiumi T; Tada Y; Song Y; Kashiwagi E; Masubuchi D; Naito S
BJU Int; 2011 Jul; 108(2 Pt 2):E142-9. PubMed ID: 21083641
[TBL] [Abstract][Full Text] [Related]
3. Foxo3a suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation.
Shiota M; Song Y; Yokomizo A; Kiyoshima K; Tada Y; Uchino H; Uchiumi T; Inokuchi J; Oda Y; Kuroiwa K; Tatsugami K; Naito S
Clin Cancer Res; 2010 Dec; 16(23):5654-63. PubMed ID: 21138866
[TBL] [Abstract][Full Text] [Related]
4. Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth.
Shiota M; Izumi H; Tanimoto A; Takahashi M; Miyamoto N; Kashiwagi E; Kidani A; Hirano G; Masubuchi D; Fukunaka Y; Yasuniwa Y; Naito S; Nishizawa S; Sasaguri Y; Kohno K
Cancer Res; 2009 Apr; 69(7):3148-56. PubMed ID: 19318582
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of PCAF endows apoptosis resistance in cisplatin-resistant cells.
Hirano G; Izumi H; Kidani A; Yasuniwa Y; Han B; Kusaba H; Akashi K; Kuwano M; Kohno K
Mol Cancer Res; 2010 Jun; 8(6):864-72. PubMed ID: 20530585
[TBL] [Abstract][Full Text] [Related]
6. Interaction between docetaxel resistance and castration resistance in prostate cancer: implications of Twist1, YB-1, and androgen receptor.
Shiota M; Kashiwagi E; Yokomizo A; Takeuchi A; Dejima T; Song Y; Tatsugami K; Inokuchi J; Uchiumi T; Naito S
Prostate; 2013 Sep; 73(12):1336-44. PubMed ID: 23775496
[TBL] [Abstract][Full Text] [Related]
7. Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil.
Liu T; Wang X; Hu W; Fang Z; Jin Y; Fang X; Miao QR
Neoplasia; 2019 Jun; 21(6):557-570. PubMed ID: 31042625
[TBL] [Abstract][Full Text] [Related]
8. Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1.
Sengupta S; Mantha AK; Mitra S; Bhakat KK
Oncogene; 2011 Jan; 30(4):482-93. PubMed ID: 20856196
[TBL] [Abstract][Full Text] [Related]
9. PCAF-mediated acetylation of ISX recruits BRD4 to promote epithelial-mesenchymal transition.
Wang LT; Liu KY; Jeng WY; Chiang CM; Chai CY; Chiou SS; Huang MS; Yokoyama KK; Wang SN; Huang SK; Hsu SH
EMBO Rep; 2020 Feb; 21(2):e48795. PubMed ID: 31908141
[TBL] [Abstract][Full Text] [Related]
10. Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer.
Song YH; Shiota M; Yokomizo A; Uchiumi T; Kiyoshima K; Kuroiwa K; Oda Y; Naito S
Urol Oncol; 2014 Jan; 32(1):31.e1-7. PubMed ID: 23395237
[TBL] [Abstract][Full Text] [Related]
11. Functional interplay between CBP and PCAF in acetylation and regulation of transcription factor KLF13 activity.
Song CZ; Keller K; Chen Y; Stamatoyannopoulos G
J Mol Biol; 2003 May; 329(2):207-15. PubMed ID: 12758070
[TBL] [Abstract][Full Text] [Related]
12. Twist promotes tumor cell growth through YB-1 expression.
Shiota M; Izumi H; Onitsuka T; Miyamoto N; Kashiwagi E; Kidani A; Yokomizo A; Naito S; Kohno K
Cancer Res; 2008 Jan; 68(1):98-105. PubMed ID: 18172301
[TBL] [Abstract][Full Text] [Related]
13. hSirT1-dependent regulation of the PCAF-E2F1-p73 apoptotic pathway in response to DNA damage.
Pediconi N; Guerrieri F; Vossio S; Bruno T; Belloni L; Schinzari V; Scisciani C; Fanciulli M; Levrero M
Mol Cell Biol; 2009 Apr; 29(8):1989-98. PubMed ID: 19188449
[TBL] [Abstract][Full Text] [Related]
14. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW
J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279
[TBL] [Abstract][Full Text] [Related]
15. P300/CBP-associated factor (PCAF)-mediated acetylation of Fascin at lysine 471 inhibits its actin-bundling activity and tumor metastasis in esophageal cancer.
Cheng YW; Zeng FM; Li DJ; Wang SH; He JZ; Guo ZC; Nie PJ; Wu ZY; Shi WQ; Wen B; Xu XE; Liao LD; Li ZM; Wu JY; Zhan J; Zhang HQ; Chang ZJ; Zhang K; Xu LY; Li EM
Cancer Commun (Lond); 2021 Dec; 41(12):1398-1416. PubMed ID: 34555274
[TBL] [Abstract][Full Text] [Related]
16. The histone acetyltransferase activity of PCAF cooperates with the brahma/SWI2-related protein BRG-1 in the activation of the enhancer A of the MHC class I promoter.
Brockmann D; Lehmkühler O; Schmücker U; Esche H
Gene; 2001 Oct; 277(1-2):111-20. PubMed ID: 11602348
[TBL] [Abstract][Full Text] [Related]
17. Histone Acetyltransferase p300/CREB-binding Protein-associated Factor (PCAF) Is Required for All-
Sunami Y; Araki M; Kan S; Ito A; Hironaka Y; Imai M; Morishita S; Ohsaka A; Komatsu N
J Biol Chem; 2017 Feb; 292(7):2815-2829. PubMed ID: 28053092
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone activation of matrix metalloproteinase-13 transcription requires the histone acetyltransferase activity of p300 and PCAF and p300-dependent acetylation of PCAF.
Lee M; Partridge NC
J Biol Chem; 2010 Dec; 285(49):38014-22. PubMed ID: 20870727
[TBL] [Abstract][Full Text] [Related]
19. The twist box domain is required for Twist1-induced prostate cancer metastasis.
Gajula RP; Chettiar ST; Williams RD; Thiyagarajan S; Kato Y; Aziz K; Wang R; Gandhi N; Wild AT; Vesuna F; Ma J; Salih T; Cades J; Fertig E; Biswal S; Burns TF; Chung CH; Rudin CM; Herman JM; Hales RK; Raman V; An SS; Tran PT
Mol Cancer Res; 2013 Nov; 11(11):1387-400. PubMed ID: 23982216
[TBL] [Abstract][Full Text] [Related]
20. miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells.
Gong AY; Eischeid AN; Xiao J; Zhao J; Chen D; Wang ZY; Young CY; Chen XM
BMC Cancer; 2012 Oct; 12():492. PubMed ID: 23095762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
